Vertex Pharmaceuticals is backed by CF dominance and JOURNAVX optionality, with key catalysts ahead for growth and upside.

Cystic fibrosis patients rarely used to see age 30. Now, with this Iowa doctor's work, people are living well into their 80s ...

Michael J. Welsh, MD, University of Iowa professor of internal medicine, has won the 2025 Lasker-DeBakey Clinical Medical ...

The Lasker Foundation today announced the winners of its 2025 Lasker Awards: Dirk Görlich and Steven L. McKnight will receive the Albert Lasker Basic Medical Research Award; Michael J. Welsh, Jesús ...

González, Paul Negulescu, and Michael Welsh received the 2025 Lasker Clinical Medical Research Award for the development of a ...

This was the shared view of Communications Minister Fahmi Fadzil and Capital A Bhd CEO Tan Sri Tony Fernandes, who shared the ...

New solar panels, battery energy storage systems, factory announcements and more are set to be unveiled at RE+ Las Vegas, ...

Different vacuums are better suited for cleaning hard floors or carpeting, and some feature heads that raise or lower to meet ...

Just using simple geometric ideas, Indian mathematicians estimated the height of Mount Everest which was its official height ...

Zai Lab Limited ( NASDAQ: ZLAB) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 2:35 PM EDT ...

RE+ 2025 showcases new solar modules, energy storage systems and factory expansions this week in Las Vegas for more than 40,000 industry professionals and 1,300 exhibitors.

Vertex Pharmaceuticals has a lot of buy and hold ratings, but there aren't any sell ratings from Wall Street analysts. Around ...